MXPA03000033A - Method of treating peripheral vascular diseases, peripheral neuropathies, and autonomic neuropathies. - Google Patents

Method of treating peripheral vascular diseases, peripheral neuropathies, and autonomic neuropathies.

Info

Publication number
MXPA03000033A
MXPA03000033A MXPA03000033A MXPA03000033A MXPA03000033A MX PA03000033 A MXPA03000033 A MX PA03000033A MX PA03000033 A MXPA03000033 A MX PA03000033A MX PA03000033 A MXPA03000033 A MX PA03000033A MX PA03000033 A MXPA03000033 A MX PA03000033A
Authority
MX
Mexico
Prior art keywords
neuropathies
peripheral
vascular diseases
autonomic
treating
Prior art date
Application number
MXPA03000033A
Other languages
Spanish (es)
Inventor
Ralph E Wood
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of MXPA03000033A publication Critical patent/MXPA03000033A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pain & Pain Management (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Ophthalmology & Optometry (AREA)
  • Rheumatology (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
MXPA03000033A 2000-06-30 2001-06-29 Method of treating peripheral vascular diseases, peripheral neuropathies, and autonomic neuropathies. MXPA03000033A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US21506500P 2000-06-30 2000-06-30
US21902900P 2000-07-18 2000-07-18
PCT/US2001/041202 WO2002002118A1 (en) 2000-06-30 2001-06-29 Method of treating peripheral vascular diseases, peripheral neuropathies, and autonomic neuropathies

Publications (1)

Publication Number Publication Date
MXPA03000033A true MXPA03000033A (en) 2003-09-25

Family

ID=26909649

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA03000033A MXPA03000033A (en) 2000-06-30 2001-06-29 Method of treating peripheral vascular diseases, peripheral neuropathies, and autonomic neuropathies.

Country Status (13)

Country Link
EP (1) EP1303279A1 (en)
JP (1) JP2004511433A (en)
KR (1) KR20030047907A (en)
CN (1) CN1440287A (en)
AU (1) AU2001279275A1 (en)
BR (1) BR0112100A (en)
CA (1) CA2414352A1 (en)
HU (1) HUP0301451A3 (en)
IL (1) IL153426A0 (en)
MX (1) MXPA03000033A (en)
NZ (1) NZ523108A (en)
PL (1) PL365565A1 (en)
WO (1) WO2002002118A1 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0020588D0 (en) * 2000-08-21 2000-10-11 Pfizer Ltd Treatment of wounds
US8133903B2 (en) 2003-10-21 2012-03-13 Los Angeles Biomedical Research Institute at Harbor—UCLA Medical Center Methods of use of inhibitors of phosphodiesterases and modulators of nitric oxide, reactive oxygen species, and metalloproteinases in the treatment of peyronie's disease, arteriosclerosis and other fibrotic diseases
MXPA05009242A (en) * 2003-03-17 2006-04-18 Pfizer Prod Inc Treatment of type 1 diabetes with pde5 inhibitors.
FR2877013A1 (en) * 2004-10-27 2006-04-28 Assist Publ Hopitaux De Paris INDENTIFICATION OF A JAK2 MUTATION INVOLVED IN THE VAQUEZ POLYGLOBULIA
WO2006074443A2 (en) * 2005-01-07 2006-07-13 The Johns Hopkins University Pde5 inhibitor compositions and methods for immunotherapy
MX2017016930A (en) * 2017-12-19 2019-06-20 Malesil Research & Tech Llc Method of treatment of diabetic foot ulcers.

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6043252A (en) * 1997-05-05 2000-03-28 Icos Corporation Carboline derivatives
US6075028A (en) * 1999-09-23 2000-06-13 Graham; Richard Method of treating Tourette's syndrome and related CNS disorders

Also Published As

Publication number Publication date
KR20030047907A (en) 2003-06-18
JP2004511433A (en) 2004-04-15
NZ523108A (en) 2005-04-29
WO2002002118A1 (en) 2002-01-10
EP1303279A1 (en) 2003-04-23
BR0112100A (en) 2003-05-20
CN1440287A (en) 2003-09-03
IL153426A0 (en) 2003-07-06
HUP0301451A2 (en) 2003-09-29
HUP0301451A3 (en) 2004-10-28
CA2414352A1 (en) 2002-01-10
AU2001279275A1 (en) 2002-01-14
PL365565A1 (en) 2005-01-10

Similar Documents

Publication Publication Date Title
IL162447A0 (en) Methods for slowing senescence and treating and preventing diseases associated with senescence
MXPA01009544A (en) Method for treating and/or preventing retinal diseases with sustained release corticosteroids.
DE60019473D1 (en) (S, S) reboxetine for the treatment of peripheral neuropathies
EP1480658A4 (en) Methods of treating vascular disease
MXPA03007816A (en) Disposable underpants and method of providing the same.
EP1455778A4 (en) Methods for the treatment of peripheral neural and vascular ailments
DK1373215T3 (en) Gelanamycin derivatives suitable for the treatment of cancer
ZA200108446B (en) Novel method of treatment.
ZA200300418B (en) Method of treating cardiovascular disease.
MXPA03000188A (en) Methods of treating neutrophil-related diseases with topical anesthetics.
MXPA03003836A (en) Foam treatment of tissue products.
MXPA03008582A (en) Agents and methods for treatment of cancer.
MXPA03003741A (en) Methods and compositions for the treatment of diseases of the eye.
ZA200003768B (en) Methods and compositions for treating diseases and conditions of the eye.
WO2003063725A3 (en) Methods of preventing and treating flavivirus infection in animals
MXPA03006776A (en) Use of il-18 inhibitors for the treatment and/or prevention of heart disease.
IL138692A0 (en) Treatment and prevention of vascular disease
MXPA03000033A (en) Method of treating peripheral vascular diseases, peripheral neuropathies, and autonomic neuropathies.
HK1041661A1 (en) Electromedical treatment applicator.
ZA200004363B (en) Treatment or prevention of coccidiosis.
MXPA03003032A (en) Combination therapy for the treatment of estrogen-sensitive disease.
AU2002330724A1 (en) Diagnosis, prevention and treatment of cancer
MXPA03004449A (en) Cosmetic method of treating skin.
ZA200209632B (en) Methods for prevention of ulcers and improving physiological performance.
ZA200203166B (en) Treatment of cancer.